DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 75 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
Novadoz Pharmaceuticals LLC
Pradaxa
dabigatran etexilate
Listed by Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 110 mg/1
- Form
- Pellet
- Route
- Oral
- Class
- Direct Thrombin Inhibitor
What it contains
- Dabigatran Etexilate Mesylate 110 mg/1
FDA record
| Dosage form | Pellet |
|---|---|
| Route | Oral |
| Drug class | Direct Thrombin Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0597-0445 |
| FDA application | NDA214358 |
| RxNorm concept | 2590616 |
| Package sizes listed | 1 |
| Marketed since | March 2022 |
Other products containing Dabigatran Etexilate
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
AvKARE
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
American Health Packaging
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 75 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
A-S Medication Solutions
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
AvPAK
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 75 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
AvKARE
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 150 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
A-S Medication Solutions
DABIGATRAN
DABIGATRAN ETEXILATE
- Strength
- 75 mg/1
- Form
- Capsule
- Class
- Direct Thrombin Inhibitor
American Health Packaging
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.